How a new Trump plan could make science ‘a political football’ The NIH is already in turmoil. Billlions of dol ...

The patent on weight loss injection semaglutide is due to expire in 2031, which will let other companies make cut-price versions of the same drug ...

Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...

Novo Nordisk's limited-time coupon on Wegovy was simultaneously promoted by telehealth companies Ro and Wegovy ...

A report released Thursday said highly processed foods, exposure to chemicals and excessive use of prescription drugs are ...

Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of the medication.

They're brightly colored, packed in enticing boxes and often marketed as healthy -- but many cereals today are actually less ...

Wegovy belongs to a pricey class of drugs called GLP-1s (short for glucagon-like peptide-1 agonists) that have upended the ...

It's plainly apparent that Novo Nordisk has had May 22 circled its calendar since February, when the FDA began the countdown ...

Health plan sponsors are also expected to see a reduction in the net cost per prescription of GLP-1 medications to treat obesity.

Over the past six months, Eli Lilly has earned significant wins over its Denmark-based rival and is still at it. Recent clinical trial results Eli Lilly released suggest that it is building a lead in ...